• Consensus Rating: Hold
  • Consensus Price Target: C$18.34
  • Forecasted Upside:
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00
+0.30 (1.20%)

This chart shows the closing price for APHA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aphria Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APHA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APHA

Analyst Price Target is C$18.34
▲ +∞ Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Aphria in the last 3 months. The average price target is C$18.34, with a high forecast of C$28.00 and a low forecast of C$10.75. The average price target represents a ∞ upside from the last price of C$0.00.

This chart shows the closing price for APHA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 contributing investment analysts is to hold stock in Aphria. This rating has held steady since December 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/13/2021Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$17.50
4/13/2021Haywood SecuritiesLower Price TargetHoldC$26.00 ➝ C$20.00
4/13/2021Pi FinancialDowngradeBuy ➝ NeutralC$11.00 ➝ C$16.00
4/13/2021Standpoint ResearchLower Price TargetNeutralC$22.00 ➝ C$18.00
4/12/2021CIBCBoost Price TargetOutperformC$28.00
4/6/2021Stifel NicolausBoost Price TargetC$15.50 ➝ C$22.00
1/19/2021Stifel NicolausBoost Price TargetC$9.80 ➝ C$15.50
1/15/2021Alliance Global PartnersSet Price TargetC$20.00
1/15/2021Haywood SecuritiesDowngradeBuy ➝ HoldC$12.25 ➝ C$14.00
1/15/2021Canaccord GenuityUpgradeHold ➝ Speculative BuyC$11.00 ➝ C$17.50
1/15/2021CIBCBoost Price TargetC$12.50 ➝ C$18.00
12/18/2020CormarkBoost Price TargetC$8.00 ➝ C$10.75
12/18/2020Canaccord GenuityDowngradeSpeculative Buy ➝ Hold
12/17/2020Pi FinancialSet Price TargetBuyC$11.00
12/17/2020Stifel NicolausDowngradeBuy ➝ HoldC$8.25 ➝ C$9.80
12/17/2020Alliance Global PartnersBoost Price TargetC$9.00 ➝ C$12.00
12/4/2020Jefferies Financial GroupBoost Price TargetC$9.42 ➝ C$12.80
12/2/2020Haywood SecuritiesBoost Price TargetC$8.25 ➝ C$12.25
11/13/2020CormarkBoost Price TargetC$7.00 ➝ C$8.00
11/9/2020Pi FinancialBoost Price TargetBuyC$10.00 ➝ C$11.00
11/5/2020Canaccord GenuityBoost Price TargetC$10.00 ➝ C$11.00
10/22/2020Jefferies Financial GroupLower Price TargetC$10.00 ➝ C$9.42
10/16/2020CormarkBoost Price TargetC$6.00 ➝ C$7.00
10/16/2020CIBCBoost Price TargetC$7.50 ➝ C$8.00
10/16/2020Pi FinancialSet Price TargetBuyC$10.00
10/9/2020Stifel NicolausBoost Price TargetC$8.00 ➝ C$8.25
8/5/2020Jefferies Financial GroupLower Price TargetC$9.00 ➝ C$7.00
7/30/2020Pi FinancialBoost Price TargetBuyC$8.00 ➝ C$10.00
7/30/2020CIBCBoost Price TargetC$6.00 ➝ C$7.50
4/16/2020CIBCLower Price TargetC$7.00 ➝ C$6.00
4/16/2020Eight CapitalUpgradeNeutral ➝ BuyC$9.00 ➝ C$8.00
4/16/2020Jefferies Financial GroupLower Price TargetC$10.00 ➝ C$9.00
4/16/2020Stifel NicolausBoost Price TargetC$4.50 ➝ C$5.30
4/14/2020Pi FinancialSet Price TargetBuyC$8.00
3/19/2020Bank of AmericaUpgradeNeutral ➝ Buy
2/19/2020Bryan, Garnier & CoLower Price TargetC$12.40 ➝ C$6.50
1/21/2020Alliance Global PartnersReiterated RatingBuyC$11.00
1/20/2020Jefferies Financial GroupLower Price TargetC$11.00 ➝ C$10.30
1/15/2020Pi FinancialLower Price TargetBuyC$9.00 ➝ C$8.00
1/15/2020CIBCUpgradeUnderperform ➝ NeutralC$6.50 ➝ C$7.00
10/16/2019CormarkLower Price TargetC$14.00 ➝ C$8.00
10/16/2019Eight CapitalLower Price TargetC$11.00 ➝ C$9.00
10/16/2019CIBCLower Price TargetC$7.00 ➝ C$6.50
10/11/2019Jefferies Financial GroupLower Price TargetC$15.00 ➝ C$11.00
8/2/2019CIBCBoost Price TargetC$6.50 ➝ C$7.00
7/26/2019CIBCLower Price TargetC$12.00 ➝ C$6.50
6/19/2019Canaccord GenuityLower Price TargetC$18.00 ➝ C$16.00
5/24/2019Jefferies Financial GroupReiterated RatingBuyC$15.00
4/17/2019CormarkLower Price TargetC$15.00 ➝ C$14.00
4/16/2019CIBCBoost Price TargetC$10.00 ➝ C$12.00
10/14/2018Bryan, Garnier & CoSet Price TargetBuyC$31.00
7/18/2018Canaccord GenuityLower Price TargetC$11.25C$25.50 ➝ C$24.50
1/30/2018Canaccord GenuityBoost Price TargetC$23.50 ➝ C$26.50
1/11/2018Canaccord GenuitySet Price TargetSpeculative BuyC$23.00
1/11/2018Pi FinancialBoost Price TargetC$14.00 ➝ C$25.00
12/5/2017Canaccord GenuityBoost Price TargetC$8.25 ➝ C$14.00
(Data available from 11/28/2016 forward)

News Sentiment Rating

0.47 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/2/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/1/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/1/2021
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/31/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/30/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
9/29/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/29/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/28/2021

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Aphria logo
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: C$16.57
Low: C$16.55
High: C$17.53

52 Week Range

Now: N/A

Volume

9,609,357 shs

Average Volume

6,161,365 shs

Market Capitalization

C$5.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aphria?

The following Wall Street sell-side analysts have issued reports on Aphria in the last twelve months: Alliance Global Partners, Canaccord Genuity, CIBC, Cormark, Haywood Securities, Jefferies Financial Group Inc., Pi Financial, Standpoint Research, and Stifel Nicolaus.
View the latest analyst ratings for APHA.

What is the current price target for Aphria?

9 Wall Street analysts have set twelve-month price targets for Aphria in the last year. Their average twelve-month price target is C$18.34. CIBC has the highest price target set, predicting APHA will reach C$28.00 in the next twelve months. Cormark has the lowest price target set, forecasting a price of C$10.75 for Aphria in the next year.
View the latest price targets for APHA.

What is the current consensus analyst rating for Aphria?

Aphria currently has 5 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in APHA, but not buy more shares or sell existing shares.
View the latest ratings for APHA.

How do I contact Aphria's investor relations team?

Aphria's physical mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company's listed phone number is 844-427-4742. The official website for Aphria is www.aphria.com.